SM

Sabby Management Portfolio holdings

AUM $13M
This Quarter Return
-0.35%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$396M
AUM Growth
+$396M
Cap. Flow
-$33.8M
Cap. Flow %
-8.54%
Top 10 Hldgs %
35.42%
Holding
254
New
59
Increased
32
Reduced
45
Closed
40

Sector Composition

1 Healthcare 57.32%
2 Energy 8.8%
3 Technology 1.44%
4 Communication Services 1.02%
5 Industrials 0.84%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GEVA
226
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
-3,013 Closed -$294K
PCYC
227
DELISTED
PHARMACYCLICS INC
PCYC
0
SLXP
228
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
0
DARA
229
DELISTED
DARA BIOSCIENCES INC COM STK (DE)
DARA
-117,370 Closed -$86K
CTIC
230
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
-331,627 Closed -$600K
CYTR
231
DELISTED
CytRx Corp
CYTR
0
RXII
232
DELISTED
GALENA BIOPHARMA INC COM
RXII
-3,436,456 Closed -$4.78M
CHL
233
DELISTED
China Mobile Limited
CHL
0
CELG
234
DELISTED
Celgene Corp
CELG
-22,225 Closed -$2.56M
RPTP
235
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
0
ANAC
236
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
0
AM
237
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
0
HUM icon
238
Humana
HUM
$36.5B
0
BHC icon
239
Bausch Health
BHC
$2.74B
0
BIIB icon
240
Biogen
BIIB
$19.4B
0
BLRX
241
BioLineRX
BLRX
$16.2M
-744,401 Closed -$1.57M
BLUE
242
DELISTED
bluebird bio
BLUE
0
BMRN icon
243
BioMarin Pharmaceuticals
BMRN
$11.2B
0
BMY icon
244
Bristol-Myers Squibb
BMY
$96B
0
CASI icon
245
CASI Pharmaceuticals
CASI
$35.8M
$0 ﹤0.01% +243,201 New
CERS icon
246
Cerus
CERS
$251M
-100,000 Closed -$417K